Credit Suisse Maintains Neutral on Cross Country Healthcare, Lowers Price Target to $26
Portfolio Pulse from richadhand@benzinga.com
Credit Suisse analyst Jonathan Yong has maintained a Neutral rating on Cross Country Healthcare (NASDAQ:CCRN) and lowered the price target from $27 to $26.
August 08, 2023 | 12:15 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Credit Suisse has maintained a Neutral rating on Cross Country Healthcare and lowered the price target from $27 to $26.
The news directly pertains to Cross Country Healthcare (CCRN). The lowered price target could indicate a potential decrease in the stock's value, but the maintained Neutral rating suggests that the overall outlook for the company remains stable. This could lead to a neutral short-term impact on the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100